Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 29 | 2019 | 208 | 2.120 |
Why?
|
| Lung | 27 | 2020 | 957 | 2.060 |
Why?
|
| Respiration, Artificial | 15 | 2025 | 295 | 2.040 |
Why?
|
| Positive-Pressure Respiration | 16 | 2025 | 51 | 1.990 |
Why?
|
| Pulmonary Gas Exchange | 13 | 2012 | 43 | 1.390 |
Why?
|
| Fluorodeoxyglucose F18 | 15 | 2016 | 98 | 1.120 |
Why?
|
| Respiratory Mechanics | 8 | 2025 | 56 | 1.030 |
Why?
|
| Acute Lung Injury | 7 | 2014 | 45 | 0.900 |
Why?
|
| Ventilator-Induced Lung Injury | 3 | 2019 | 10 | 0.820 |
Why?
|
| Pulmonary Ventilation | 11 | 2012 | 38 | 0.800 |
Why?
|
| Lung Diseases | 2 | 2019 | 182 | 0.750 |
Why?
|
| Pneumonia | 6 | 2019 | 290 | 0.740 |
Why?
|
| Sheep | 21 | 2016 | 181 | 0.740 |
Why?
|
| Pulmonary Circulation | 8 | 2015 | 27 | 0.720 |
Why?
|
| Intraoperative Care | 3 | 2022 | 38 | 0.690 |
Why?
|
| Ventilators, Mechanical | 3 | 2011 | 30 | 0.610 |
Why?
|
| Molecular Imaging | 1 | 2019 | 48 | 0.600 |
Why?
|
| Interleukin-6 | 1 | 2019 | 320 | 0.530 |
Why?
|
| Radiopharmaceuticals | 13 | 2016 | 190 | 0.500 |
Why?
|
| Asthma | 8 | 2019 | 466 | 0.470 |
Why?
|
| Nitrogen Radioisotopes | 14 | 2013 | 16 | 0.470 |
Why?
|
| Prone Position | 4 | 2009 | 28 | 0.450 |
Why?
|
| Patient Handoff | 1 | 2015 | 35 | 0.440 |
Why?
|
| Smoke Inhalation Injury | 1 | 2014 | 3 | 0.430 |
Why?
|
| Checklist | 1 | 2015 | 73 | 0.430 |
Why?
|
| Supine Position | 6 | 2013 | 33 | 0.410 |
Why?
|
| Animals | 28 | 2019 | 20715 | 0.340 |
Why?
|
| Respiration | 4 | 2012 | 89 | 0.330 |
Why?
|
| Tomography, Emission-Computed | 5 | 2004 | 42 | 0.330 |
Why?
|
| Respiratory Insufficiency | 2 | 2025 | 154 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 1641 | 0.310 |
Why?
|
| Inflammation | 9 | 2014 | 1146 | 0.300 |
Why?
|
| Tidal Volume | 7 | 2022 | 41 | 0.300 |
Why?
|
| Neutrophil Activation | 2 | 2009 | 23 | 0.280 |
Why?
|
| Anesthesia, General | 3 | 2012 | 46 | 0.280 |
Why?
|
| Humans | 39 | 2025 | 63527 | 0.260 |
Why?
|
| Pharmaceutical Preparations | 3 | 1998 | 123 | 0.250 |
Why?
|
| Respiratory Function Tests | 6 | 2019 | 190 | 0.240 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 2196 | 0.230 |
Why?
|
| Abdomen | 1 | 2025 | 92 | 0.220 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 741 | 0.220 |
Why?
|
| Hypoxia | 1 | 2025 | 115 | 0.220 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 65 | 0.220 |
Why?
|
| Aortic Diseases | 1 | 2005 | 65 | 0.210 |
Why?
|
| Perioperative Care | 1 | 2025 | 85 | 0.210 |
Why?
|
| Bronchoconstriction | 5 | 2012 | 9 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 243 | 0.190 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 218 | 0.180 |
Why?
|
| Lung Volume Measurements | 4 | 2013 | 20 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2025 | 1278 | 0.170 |
Why?
|
| Models, Biological | 8 | 2012 | 1182 | 0.170 |
Why?
|
| Anesthetics, Local | 2 | 1999 | 71 | 0.160 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 695 | 0.160 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 53 | 0.160 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1999 | 24 | 0.160 |
Why?
|
| Anesthesia, Spinal | 1 | 1999 | 31 | 0.150 |
Why?
|
| Ventilation-Perfusion Ratio | 4 | 2011 | 11 | 0.150 |
Why?
|
| Deglutition Disorders | 1 | 1999 | 42 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2015 | 659 | 0.150 |
Why?
|
| Electrophoresis, Capillary | 1 | 1998 | 7 | 0.140 |
Why?
|
| Benzalkonium Compounds | 1 | 1998 | 4 | 0.140 |
Why?
|
| Lung Injury | 2 | 2015 | 34 | 0.140 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1997 | 34 | 0.140 |
Why?
|
| Acute Disease | 1 | 2019 | 669 | 0.140 |
Why?
|
| Running | 1 | 1997 | 84 | 0.130 |
Why?
|
| Oxygenators, Membrane | 1 | 1996 | 6 | 0.120 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 5 | 0.120 |
Why?
|
| Male | 21 | 2025 | 29931 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 457 | 0.120 |
Why?
|
| Hydrochloric Acid | 1 | 2015 | 2 | 0.120 |
Why?
|
| Respiratory Aspiration | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cytokines | 1 | 2019 | 934 | 0.110 |
Why?
|
| Leukocyte Count | 3 | 2013 | 99 | 0.110 |
Why?
|
| Female | 21 | 2025 | 32939 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2015 | 47 | 0.110 |
Why?
|
| Endotoxemia | 2 | 2014 | 11 | 0.110 |
Why?
|
| Neutrophils | 3 | 2014 | 376 | 0.110 |
Why?
|
| Adult | 16 | 2025 | 16895 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 106 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 1999 | 536 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2015 | 285 | 0.100 |
Why?
|
| Gene Expression | 1 | 2016 | 843 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 174 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 265 | 0.100 |
Why?
|
| Anesthesiology | 1 | 2012 | 42 | 0.090 |
Why?
|
| Pulmonary Surfactants | 1 | 2011 | 12 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3401 | 0.090 |
Why?
|
| Eosinophils | 1 | 2011 | 48 | 0.090 |
Why?
|
| Respiratory System | 1 | 2011 | 46 | 0.090 |
Why?
|
| Pulmonary Embolism | 2 | 2003 | 173 | 0.090 |
Why?
|
| Glucose | 1 | 2014 | 468 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2015 | 519 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1989 | 151 | 0.080 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2010 | 4 | 0.080 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 8 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2184 | 0.080 |
Why?
|
| Theobromine | 1 | 1989 | 2 | 0.080 |
Why?
|
| Pentoxifylline | 1 | 1989 | 8 | 0.080 |
Why?
|
| Middle Aged | 9 | 2025 | 17656 | 0.080 |
Why?
|
| Thiophenes | 1 | 1989 | 29 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 225 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2012 | 16 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 297 | 0.070 |
Why?
|
| Biomarkers | 4 | 2016 | 1405 | 0.070 |
Why?
|
| Smoke | 1 | 2007 | 24 | 0.070 |
Why?
|
| Aged | 7 | 2025 | 14451 | 0.060 |
Why?
|
| Blood Gas Analysis | 3 | 2010 | 34 | 0.060 |
Why?
|
| Oxygen Radioisotopes | 1 | 2005 | 4 | 0.060 |
Why?
|
| Kinetics | 3 | 2014 | 763 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2005 | 123 | 0.050 |
Why?
|
| Elective Surgical Procedures | 1 | 2025 | 115 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 3 | 1989 | 47 | 0.050 |
Why?
|
| Diagnostic Techniques, Radioisotope | 1 | 2003 | 1 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 180 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1989 | 230 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2004 | 514 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2025 | 407 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2005 | 219 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2012 | 1120 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 332 | 0.050 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 623 | 0.040 |
Why?
|
| Spirometry | 2 | 2012 | 112 | 0.040 |
Why?
|
| Radiography | 2 | 2012 | 551 | 0.040 |
Why?
|
| Hypercapnia | 1 | 2000 | 9 | 0.040 |
Why?
|
| Young Adult | 4 | 2012 | 4714 | 0.040 |
Why?
|
| Nicardipine | 2 | 1990 | 3 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 13 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 27 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 1151 | 0.040 |
Why?
|
| Chemistry | 2 | 1989 | 31 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2007 | 477 | 0.040 |
Why?
|
| Chemical Phenomena | 2 | 1989 | 95 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 387 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 330 | 0.040 |
Why?
|
| Cesarean Section | 1 | 1999 | 102 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2025 | 3293 | 0.040 |
Why?
|
| Technology, Pharmaceutical | 1 | 1998 | 20 | 0.040 |
Why?
|
| Methacholine Chloride | 2 | 2009 | 23 | 0.030 |
Why?
|
| Drug Stability | 1 | 1998 | 143 | 0.030 |
Why?
|
| Electrochemistry | 2 | 1988 | 27 | 0.030 |
Why?
|
| Activation, Metabolic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 1997 | 271 | 0.030 |
Why?
|
| Lung Compliance | 1 | 1996 | 5 | 0.030 |
Why?
|
| Porosity | 1 | 1996 | 39 | 0.030 |
Why?
|
| Plasma | 1 | 1996 | 37 | 0.030 |
Why?
|
| Gallium Radioisotopes | 1 | 2015 | 15 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 1996 | 96 | 0.030 |
Why?
|
| Microspheres | 1 | 2015 | 57 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 1997 | 381 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 30 | 0.030 |
Why?
|
| Algorithms | 3 | 2003 | 1004 | 0.030 |
Why?
|
| Surface-Active Agents | 1 | 2014 | 113 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 980 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 60 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 103 | 0.020 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2012 | 5 | 0.020 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 11 | 0.020 |
Why?
|
| One-Lung Ventilation | 1 | 2012 | 5 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 1664 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 24 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 57 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 6259 | 0.020 |
Why?
|
| Anesthesia | 1 | 2012 | 50 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2012 | 63 | 0.020 |
Why?
|
| Pregnancy | 1 | 1999 | 2335 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 937 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2012 | 209 | 0.020 |
Why?
|
| United States | 1 | 2025 | 7836 | 0.020 |
Why?
|
| Cats | 1 | 2011 | 87 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 134 | 0.020 |
Why?
|
| Allergens | 1 | 2011 | 53 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 408 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 1991 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 110 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2011 | 69 | 0.020 |
Why?
|
| Atenolol | 1 | 1990 | 9 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 291 | 0.020 |
Why?
|
| Propranolol | 1 | 1990 | 20 | 0.020 |
Why?
|
| Exhalation | 1 | 2010 | 15 | 0.020 |
Why?
|
| Perfusion | 1 | 2010 | 72 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 158 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 570 | 0.020 |
Why?
|
| Nadolol | 1 | 1989 | 4 | 0.020 |
Why?
|
| Propanolamines | 1 | 1989 | 10 | 0.020 |
Why?
|
| Solvents | 1 | 1988 | 58 | 0.020 |
Why?
|
| Adsorption | 1 | 1988 | 84 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 267 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 314 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1988 | 94 | 0.020 |
Why?
|
| Nitriles | 1 | 1988 | 70 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 199 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2002 | 248 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 125 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1989 | 159 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Oscillometry | 1 | 2007 | 13 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 605 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2007 | 55 | 0.020 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 5 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1090 | 0.020 |
Why?
|
| Phenothiazines | 1 | 1985 | 2 | 0.020 |
Why?
|
| Alkaloids | 1 | 1985 | 12 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1985 | 19 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 53 | 0.020 |
Why?
|
| Penicillins | 1 | 1985 | 30 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 685 | 0.010 |
Why?
|
| Diuretics | 1 | 1985 | 59 | 0.010 |
Why?
|
| Critical Care | 1 | 2009 | 396 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 2026 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 271 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 286 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1985 | 127 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 134 | 0.010 |
Why?
|
| Protein Binding | 1 | 1988 | 1603 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1985 | 205 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 49 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 18 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2003 | 42 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 87 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 146 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2002 | 6 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2002 | 39 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 308 | 0.010 |
Why?
|
| Insufflation | 1 | 2000 | 9 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1990 | 127 | 0.010 |
Why?
|
| Pulse | 1 | 1990 | 15 | 0.010 |
Why?
|
| Biological Availability | 1 | 1990 | 200 | 0.000 |
Why?
|